Copyright
©The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 14, 2005; 11(38): 6003-6008
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.6003
Published online Oct 14, 2005. doi: 10.3748/wjg.v11.i38.6003
Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease
David G Cox, International Agency for Research on Cancer, Lyon, France (Current address: Molecular Epidemiology, Harvard School of Public Health, Boston, MA, USA)
J Bart A Crusius, Laboratory of Immunogenetics, VU University Medical Center, Amsterdam, The Netherlands
Petra HM Peeters, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands
H Bas Bueno-de-Mesquita, Department of Epidemiology, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands
A Salvador Peña, Laboratory of Immunogenetics and Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands
Federico Canzian, International Agency for Research on Cancer, Lyon, France (Current address: German Cancer Research Center, Heidelberg, Germany)
Author contributions: All authors contributed equally to the work.
Supported by The Grants from the International Agency for Research on Cancer (Special Training Award to DGC), the French Association for Research on Cancer (grant #7478), and the Crohn's and Colitis Foundation of America (to ASP)
Correspondence to: Federico Canzian, PhD, German Cancer Research Centre (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. f. canzian@dkfz.de
Telephone: +49-6221-421791 Fax: +49-6221-421810
Received: January 21, 2005
Revised: February 15, 2005
Accepted: February 18, 2005
Published online: October 14, 2005
Revised: February 15, 2005
Accepted: February 18, 2005
Published online: October 14, 2005
Core Tip